Capsular sialic acid limits C5a production on type III group B streptococci

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1866-1870

  Takahashi, Shinji ^a   Aoyagi, Youko ^a   Adderson, Elisabeth E ^b   Okuwaki, Yoshiyuki ^a   Bohnsack, John F ^b  

^a Department of Microbiology   (Japan)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C5A; MEMBRANE PROTEIN; SIALIC ACID;

ARTICLE; BACTERIAL VIRULENCE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; IMMUNOREGULATION; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033039452     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.4.1866-1870.1999     Document Type: Article

References (17)

1. Aminoff, D. 1961. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81:384-392.
2. Baker, C. J., and M. S. Edwards. 1995. Group B streptococcal infections, p. 980-1054. In J. S. Remington and J. O. Klein (ed.), Infectious disease of the fetus and newborn infant, 4th ed. W. B. Saunders Co. Philadelphia, Pa.
3. Baker, C. J., M. S. Edwards, B. J. Webb, and D. J. Kasper. 1982. Antibody-dependent classical pathway-mediated opsonophagocytosis of type Ia, group B Streptococcus. J. Clin. Investig. 69:394-404.
4. Blumberg, H. M., D. S. Stephens, M. Modansky, M. Erwin, J. Elliot, R. R. Facklam, A. Schuchat, W. Baughman, and M. M. Farley. 1996. Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173:365-373.
5. Bohnsack, J. F., K. W. Mollison, A. M. Buko, J. W. Ashworth, and H. R. Hill. 1991. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem. J. 273:635-640.
6. Bohnsack, J. F., K. Widjaja, S. Ghazizadeh, C. E. Rubens, D. Hillyard, C. J. Parker, K. H. Albertine, and H. R. Hill. 1997. A role for C5 in the acute neutrophil response to group B streptococcal infections. J. Infect. Dis. 175: 847-855.
7. Briesacher, M. R., J. A. Daly, K. C. Carroll, H. R. Hill, and J. F. Bohnsack. 1995. Frequency of expression of C5a-ase in human isolates of group B streptococcus. Pediatr. Res. 37:288A.
8. Edwards, M. S., D. L. Kasper, H. J. Jennings, C. J. Baker, and A. Nicholson-Weller. 1982. Capsular sialic acid prevents activation of the alternative pathway by type III, group B streptococci. J. Immunol. 128:1278-1283.
9. Edwards, M. S., M. R. Wessels, and C. J. Baker. 1993. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect. Immun. 61:2866-2871.
10. Egan, M. L., D. G. Pritchard, H. C. Dillon, Jr., and B. M. Gray. 1983. Protection of mice from experimental infection with type III group B streptococcus using monoclonal antibodies. J. Exp. Med. 158:1006-1011.
11. Hill, H. R., J. F. Bohnsack, E. Z. Morris, N. H. Augustine, C. J. Parker, P. P. Cleary, and J. T. Wu. 1988. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J. Immunol. 141:3551-3556.
12. Kogan, G., D. Uhrin, J.-R. Brisson, L. C. Paoletti, A. E. Blodgelt, D. L. Kasper, and H. J. Jennings. 1996. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J. Biol. Chem. 271:8786-8790.
13. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
14. Nagano, Y., N. Nagano, S. Takahashi, K. Murono, K. Fujita, F. Taguchi, and Y. Okuwaki. 1991. Restriction endonuclease digest patterns of chromosomal DNA from group B β-haemolytic streptococci. J. Med. Microbiol. 35:297-303.
15. Steinbuch, M., and R. Audran. 1969. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch. Biochem. Biophys. 134:279-284.
16. Takahashi, S., E. E. Adderson, Y. Nagano, N. Nagano, M. R. Briesacher, and J. F. Bohnsack. 1998. Identification of a highly encapsulated genetically related group of invasive type III GBS. J. Infect. Dis. 177:1116-1119.
17. Takahashi, S., Y. Nagano, N. Nagano, O. Hayashi, F. Taguchi, and Y. Okuwaki. 1995. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect. Immun. 63:4764-4769.